Need professional-grade analysis? Visit stockanalysis.com
$20.18B
25.41
3,471
N/A
Price Chart
Risk-Adjusted Performance
Krsnaa Diagnostics Limited (KRSNAA) Price Performance
Krsnaa Diagnostics Limited (KRSNAA) trades on NSE in INR. The company is classified in the Healthcare sector under the Diagnostics & Research industry. The stock currently trades at INR612.05, down 1.72% from the previous close.
Over the past year, KRSNAA has traded between a low of INR520.30 and a high of INR866.20. The stock has lost 26.5% over this period. It is currently 29.3% below its 52-week high.
Krsnaa Diagnostics Limited has a market capitalization of $20.18B, with a price-to-earnings ratio of 25.41.
About Krsnaa Diagnostics Limited
Krsnaa Diagnostics Limited provides diagnostic services in India. It offers a range radiology services, including computed tomography scans, magnetic resonance imaging, X-rays, and ultrasound and advanced imaging; pathology services, such as laboratory, and home collection and preventive health; and teleradiology and telepathology services. The company also provides other diagnostics services, such as ophthalmic test, mammography, dental imaging, stress test, dual-energy X-ray absorptiometry scan, and bone mineral density test. It serves individual patients, government clients, corporate clients, hospitals, clinics, private practitioner, and other healthcare providers. Krsnaa Diagnostics Limited was incorporated in 2010 and is based in Pune, India.
Compare Krsnaa Diagnostics Limited
Side-by-side comparison against top Healthcare peers.
Company Info
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Exchange
- NSE
- Currency
- INR
- Country
- India
Financial Metrics
- Revenue (TTM)
- $7.66B
- EBITDA
- $2.07B
- Profit Margin
- 10.49%
- EPS (TTM)
- 24.48
- Book Value
- 284.46
Technical Indicators
- 52 Week High
- ₹894.40
- 52 Week Low
- ₹515.00
- 50 Day MA
- ₹617.03
- 200 Day MA
- ₹745.22
- Beta
- -0.03
Valuation
- Trailing P/E
- 25.41
- Forward P/E
- N/A
- Price/Sales
- 2.63
- Price/Book
- 2.17
- Enterprise Value
- $21.25B